Hind Rafei

2.1k total citations
44 papers, 716 citations indexed

About

Hind Rafei is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, Hind Rafei has authored 44 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 17 papers in Hematology and 12 papers in Immunology. Recurrent topics in Hind Rafei's work include CAR-T cell therapy research (11 papers), Immune Cell Function and Interaction (9 papers) and Hematopoietic Stem Cell Transplantation (8 papers). Hind Rafei is often cited by papers focused on CAR-T cell therapy research (11 papers), Immune Cell Function and Interaction (9 papers) and Hematopoietic Stem Cell Transplantation (8 papers). Hind Rafei collaborates with scholars based in United States, Lebanon and Canada. Hind Rafei's co-authors include Samah Nassereddine, Imad A. Tabbara, Katayoun Rezvani, Elias Jabbour, Hagop M. Kantarjian, May Daher, Robert R. Jenq, Courtney D. DiNardo, Ye Li and Mohamed A. Kharfan‐Dabaja and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Hind Rafei

42 papers receiving 706 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hind Rafei United States 13 290 271 211 168 104 44 716
Delia Dima Romania 16 240 0.8× 173 0.6× 118 0.6× 255 1.5× 139 1.3× 70 645
Е. Н. Паровичникова Russia 11 301 1.0× 179 0.7× 107 0.5× 126 0.8× 276 2.7× 226 688
Tor Henrik Anderson Tvedt Norway 18 632 2.2× 167 0.6× 314 1.5× 176 1.0× 153 1.5× 66 1.0k
Marie Loosveld France 14 194 0.7× 133 0.5× 119 0.6× 199 1.2× 77 0.7× 46 753
Dong Soon Lee South Korea 18 575 2.0× 203 0.7× 132 0.6× 329 2.0× 252 2.4× 75 882
Leopold Oehler Austria 13 192 0.7× 173 0.6× 357 1.7× 154 0.9× 115 1.1× 21 762
Hisakazu Nishimori Japan 14 326 1.1× 168 0.6× 525 2.5× 105 0.6× 161 1.5× 82 961
Junji Tomiyama Japan 13 235 0.8× 90 0.3× 153 0.7× 110 0.7× 100 1.0× 47 565
Julius Fischer Germany 13 263 0.9× 158 0.6× 359 1.7× 152 0.9× 102 1.0× 45 852
Piotr Rzepecki Poland 15 145 0.5× 169 0.6× 152 0.7× 86 0.5× 39 0.4× 66 650

Countries citing papers authored by Hind Rafei

Since Specialization
Citations

This map shows the geographic impact of Hind Rafei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hind Rafei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hind Rafei more than expected).

Fields of papers citing papers by Hind Rafei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hind Rafei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hind Rafei. The network helps show where Hind Rafei may publish in the future.

Co-authorship network of co-authors of Hind Rafei

This figure shows the co-authorship network connecting the top 25 collaborators of Hind Rafei. A scholar is included among the top collaborators of Hind Rafei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hind Rafei. Hind Rafei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rafei, Hind & Katayoun Rezvani. (2024). Mitigating infection risks: The promise and challenge of bispecific antibodies in haematological malignancies. British Journal of Haematology. 205(3). 764–766. 4 indexed citations
2.
3.
Li, Ye, Katayoun Rezvani, & Hind Rafei. (2023). Next‐generation chimeric antigen receptors for T‐ and natural killer‐cell therapies against cancer. Immunological Reviews. 320(1). 217–235. 18 indexed citations
4.
Lin, Paul, Pei Lin, April L. Gilbert, et al.. (2023). CD70 CAR NK Cells in the Treatment of Multiple Myeloma. Blood. 142(Supplement 1). 3463–3463. 14 indexed citations
5.
Rafei, Hind, Bijender Kumar, Mayra Shanley, et al.. (2023). Radiation Therapy Sensitizes Head-and-Neck Cancer Cells to Killing by Chimeric Antigen Receptor (CAR)-NK Cells Targeting CD70. International Journal of Radiation Oncology*Biology*Physics. 117(2). S167–S168. 1 indexed citations
6.
Short, Nicholas J., Hind Rafei, Naval Daver, et al.. (2020). Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AML. Blood Advances. 4(24). 6117–6126. 22 indexed citations
7.
Alhalabi, Omar, Hind Rafei, Mehmet Asım Bilen, & Amishi Y. Shah. (2020). Current Landscape of Immunotherapy in Genitourinary Malignancies. Advances in experimental medicine and biology. 1244. 107–147. 3 indexed citations
8.
Rafei, Hind & Courtney D. DiNardo. (2019). Hereditary myeloid malignancies. Best Practice & Research Clinical Haematology. 32(2). 163–176. 26 indexed citations
9.
Rafei, Hind, Katayoun Rezvani, & Elizabeth J. Shpall. (2019). The Future of Cellular Therapy. Clinical Lymphoma Myeloma & Leukemia. 19. S102–S105. 1 indexed citations
10.
Parta, Mark, Nirali N. Shah, Kristin Baird, et al.. (2018). Allogeneic Hematopoietic Stem Cell Transplantation for GATA2 Deficiency Using a Busulfan-Based Regimen. Biology of Blood and Marrow Transplantation. 24(6). 1250–1259. 55 indexed citations
11.
Rafei, Hind & Mohamed A. Kharfan‐Dabaja. (2017). Treatment of Del17p and/or aberrant TP53 chronic lymphocytic leukemia in the era of novel therapies. Hematology/Oncology and Stem Cell Therapy. 11(1). 1–12. 6 indexed citations
12.
Rafei, Hind, et al.. (2017). A rare breed: Wild-type braf and ighv expression in a 29 year old lady with classical hairy cell leukemia. Leukemia Research Reports. 7. 20–22. 3 indexed citations
13.
Shah, Nirali N., Mark Parta, Kristin Baird, et al.. (2017). Monozygotic twins with GATA2 deficiency: same haploidentical-related donor, different severity of GvHD. Bone Marrow Transplantation. 52(11). 1580–1582. 4 indexed citations
14.
Nassereddine, Samah, et al.. (2017). Acute Graft Versus Host Disease: A Comprehensive Review. Anticancer Research. 37(4). 1547–1555. 123 indexed citations
15.
Rafei, Hind, et al.. (2017). Post-Transfusion Purpura: A Case Report of an Underdiagnosed Phenomenon. Cureus. 9(5). e1207–e1207. 8 indexed citations
16.
Rafei, Hind, et al.. (2017). Immune-based Therapies for Non-small Cell Lung Cancer. Anticancer Research. 37(2). 377–388. 62 indexed citations
17.
Aggarwal, Anita, et al.. (2016). Outcome of Patients with Double-Expressor Lymphomas (DELs) Treated with R-CHOP or R-EPOCH. Blood. 128(22). 5396–5396. 12 indexed citations
18.
Rafei, Hind, et al.. (2016). Beer Potomania: A Challenging Case of Hyponatremia. Journal of Endocrinology and Metabolism. 6(4). 123–126. 6 indexed citations
19.
Tfayli, Arafat, Alain Mina, Hind Rafei, et al.. (2015). Screening for the Prevalence of EGFR and Alk Mutations in Lung Adenocarcinoma Patients in the Levant Area, a Prospective Analysis. Annals of Oncology. 26. i1–i1. 1 indexed citations
20.
Mina, Alain, et al.. (2015). Role of baseline echocardiography prior to initiation of anthracycline-based chemotherapy in breast cancer patients. BMC Cancer. 15(1). 10–10. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Delia Dima Breakdown of academic impact, for papers by Е. Н. Паровичникова Breakdown of academic impact, for papers by Tor Henrik Anderson Tvedt Breakdown of academic impact, for papers by Marie Loosveld Breakdown of academic impact, for papers by Dong Soon Lee Breakdown of academic impact, for papers by Leopold Oehler Breakdown of academic impact, for papers by Hisakazu Nishimori Breakdown of academic impact, for papers by Junji Tomiyama Breakdown of academic impact, for papers by Julius Fischer Breakdown of academic impact, for papers by Piotr Rzepecki
Rankless by CCL
2026